Wei Ney Yap

1.0k total citations
22 papers, 762 citations indexed

About

Wei Ney Yap is a scholar working on Biochemistry, Cancer Research and Dermatology. According to data from OpenAlex, Wei Ney Yap has authored 22 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biochemistry, 6 papers in Cancer Research and 5 papers in Dermatology. Recurrent topics in Wei Ney Yap's work include Antioxidant Activity and Oxidative Stress (9 papers), Cancer, Lipids, and Metabolism (4 papers) and Skin Protection and Aging (4 papers). Wei Ney Yap is often cited by papers focused on Antioxidant Activity and Oxidative Stress (9 papers), Cancer, Lipids, and Metabolism (4 papers) and Skin Protection and Aging (4 papers). Wei Ney Yap collaborates with scholars based in Singapore, Hong Kong and Australia. Wei Ney Yap's co-authors include Yee Leng Yap, Ming Tat Ling, Chee Wai Fong, Alan Prem Kumar, Kodappully Sivaraman Siveen, Y C Wong, Haiyan Han, Y.C. Wong, Leigh C. Ward and Lindsay Brown and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Wei Ney Yap

22 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Ney Yap Singapore 13 342 266 192 133 112 22 762
Devipriya Nagarajan India 19 378 1.1× 184 0.7× 157 0.8× 150 1.1× 82 0.7× 36 1.1k
Shuya Yamashita Japan 20 448 1.3× 199 0.7× 125 0.7× 60 0.5× 35 0.3× 41 1.1k
Raghavendra S. Patwardhan India 19 614 1.8× 94 0.4× 78 0.4× 89 0.7× 99 0.9× 35 1.0k
Seung Ho Shin United States 18 484 1.4× 127 0.5× 147 0.8× 54 0.4× 68 0.6× 30 922
Andrew Hitron United States 7 385 1.1× 140 0.5× 124 0.6× 33 0.2× 58 0.5× 8 751
Amanda K. Smolarek United States 11 255 0.7× 175 0.7× 104 0.5× 91 0.7× 111 1.0× 12 646
Rahul K. Lall United States 16 424 1.2× 105 0.4× 89 0.5× 124 0.9× 62 0.6× 25 914
Kanga Rani Selvaduray Malaysia 15 278 0.8× 327 1.2× 91 0.5× 181 1.4× 175 1.6× 33 777
Sung Dae Cho South Korea 15 466 1.4× 55 0.2× 144 0.8× 56 0.4× 125 1.1× 20 929
H Wei United States 10 321 0.9× 109 0.4× 103 0.5× 101 0.8× 39 0.3× 12 1.0k

Countries citing papers authored by Wei Ney Yap

Since Specialization
Citations

This map shows the geographic impact of Wei Ney Yap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ney Yap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ney Yap more than expected).

Fields of papers citing papers by Wei Ney Yap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Ney Yap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ney Yap. The network helps show where Wei Ney Yap may publish in the future.

Co-authorship network of co-authors of Wei Ney Yap

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Ney Yap. A scholar is included among the top collaborators of Wei Ney Yap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Ney Yap. Wei Ney Yap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yap, Wei Ney, et al.. (2023). Tocotrienol-Rich Fraction Attenuates Blue Light-Induced Oxidative Stress and Melanogenesis in B16-F1 Melanocytes via Anti-Oxidative and Anti-Tyrosinase Properties. International Journal of Molecular Sciences. 24(20). 15373–15373. 2 indexed citations
2.
Makpol, Suzana, et al.. (2023). A Review on Unleashing the Potentials of Natural Products in Managing Dengue. Journal of Complementary Medicine Research. 14(2). 70–70. 1 indexed citations
3.
Yap, Wei Ney, et al.. (2022). Therapeutic effects of intranasal tocotrienol-rich fraction on rhinitis symptoms in platelet-activating factor induced allergic rhinitis. Allergy Asthma and Clinical Immunology. 18(1). 52–52. 4 indexed citations
4.
Makpol, Suzana, et al.. (2022). Effects of tocotrienol on aging skin: A systematic review. Frontiers in Pharmacology. 13. 1006198–1006198. 15 indexed citations
5.
Yeo, Mervyn, et al.. (2022). An open-label, single-arm pilot study of tocotrienols supplementation on improving memory and attention in healthy young adults. Journal of Functional Foods. 92. 105055–105055. 2 indexed citations
6.
Yap, Wei Ney, et al.. (2022). Tocotrienols improve urban particulate matter-induced skin damages by regulating skin barrier function and ROS/MAPK signalling pathway in keratinocytes. Atmospheric Pollution Research. 13(10). 101564–101564. 7 indexed citations
7.
Tey, Hong Liang, et al.. (2020). Vitamin E in Atopic Dermatitis: From Preclinical to Clinical Studies. Dermatology. 237(4). 553–564. 21 indexed citations
8.
Saw, Tzuen Yih, et al.. (2019). Oral Supplementation of Tocotrienol-Rich Fraction Alleviates Severity of Ulcerative Colitis in Mice. Journal of Nutritional Science and Vitaminology. 65(4). 318–327. 13 indexed citations
9.
Soh, Boon-Seng, et al.. (2018). Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities. Nutrition & Metabolism. 15(1). 6–6. 62 indexed citations
10.
Yap, Wei Ney. (2017). Tocotrienol‐rich fraction attenuates UV‐induced inflammaging: A bench to bedside study. Journal of Cosmetic Dermatology. 17(3). 555–565. 15 indexed citations
11.
Ward, Leigh C., et al.. (2015). Anti-inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats. Zeitschrift für Ernährungswissenschaft. 56(1). 133–150. 70 indexed citations
12.
Siveen, Kodappully Sivaraman, Kwang Seok Ahn, Tina H. Ong, et al.. (2014). γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget. 5(7). 1897–1911. 137 indexed citations
13.
Tan, Joash Ban Lee, et al.. (2014). Antioxidant Content, Antioxidant Activity, and Antibacterial Activity of Five Plants from the Commelinaceae Family. Antioxidants. 3(4). 758–769. 40 indexed citations
14.
Yap, Wei Ney, Yung‐Tuen Chiu, Stephanie Ma, et al.. (2010). Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. 5 indexed citations
15.
Yap, Wei Ney, et al.. (2010). In vivo Evidence of γ-Tocotrienol as a Chemosensitizer in the Treatment of Hormone-Refractory Prostate Cancer. Pharmacology. 85(4). 248–258. 33 indexed citations
16.
Yap, Wei Ney, Yung‐Tuen Chiu, Stephanie Ma, et al.. (2010). Gamma‐tocotrienol as an effective agent in targeting prostate cancer stem cell‐like population. International Journal of Cancer. 128(9). 2182–2191. 71 indexed citations
17.
Yap, Wei Ney, et al.. (2010). Abstract 1656: Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells. Cancer Research. 70(8_Supplement). 1656–1656. 1 indexed citations
18.
Yap, Wei Ney, et al.. (2009). Evidence ofγ-Tocotrienol as an Apoptosis-Inducing, Invasion-Suppressing, and Chemotherapy Drug-Sensitizing Agent in Human Melanoma Cells. Nutrition and Cancer. 61(3). 357–366. 63 indexed citations
19.
Yap, Wei Ney, et al.. (2009). Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells. Cancer Letters. 291(2). 187–199. 1 indexed citations
20.
Yap, Wei Ney, et al.. (2008). γ-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. British Journal of Cancer. 99(11). 1832–1841. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026